Relationships between sensitivity to hydroxyurea and 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIQ) and ribonucleotide reductase RNR2 mRNA levels in strains of Saccharomyces cerevisiae
- 1 July 1989
- journal article
- research article
- Published by Canadian Science Publishing in Biochemistry and Cell Biology
- Vol. 67 (7) , 352-357
- https://doi.org/10.1139/o89-055
Abstract
Ribonucleotide reductase is responsible for providing the deoxyribonucleotide precursors for DNA synthesis. In most species the enzyme consists of a large and a small subunit, both of which are required for activity. In mammalian cells, the small subunit is the site of action of several antitumor agents, including hydroxyurea and 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIQ). The mRNA levels for the small subunit of ribonucleotide reductase (RNR2) and sensitivity to hydroxyurea and MAIQ were determined in four strains of the yeast, Saccharomyces cerevisiae. Two strains exhibited significantly different sensitivities to both hydroxyurea and MAIQ, which closely correlated with differences in the levels of RNR2 mRNA. These results are consistent with recent observations with mammalian cells in culture, and indicate that a common mechanism of resistance to hydroxyurea and related drugs occurs through the elevation in ribonucleotide reductase message levels. A transplason mutagenized strain with marked structural modifications in RNR2 DNA and mRNA showed an extreme hypersensitivity to hydroxyurea but not to MAIQ, providing evidence that the two drugs do not inhibit the RNR2 subunit by the same mechanism. In addition, a yeast strain isolated for low but reproducible resistance to MAIQ exhibited a sensitivity to hydroxyurea similar to the parental wild-type strain, supporting the idea that the two drugs inhibit the activity of RNR2 by unique mechanisms. These yeast strains provide a useful approach for further studies into the regulation of eucaryotic ribonucleotide reduction and drug resistance mechanisms involving a key rate-limiting step in DNA synthesis.Key words: Saccharomyces cerevisiae, reductase, messenger RNA, hydroxyurea, thiosemicarbazone.This publication has 27 references indexed in Scilit:
- Increased dihydrofolate reductase activity in methotrexate-resistant human promyelocytic-leukaemia (HL-60) cells. Lack of correlation between increased activity and overproductionBiochemical Journal, 1985
- Biochemical and genetic analysis of variant mouse hepatoma cells which overtranscribe the cytochrome P1-450 gene in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin.Journal of Biological Chemistry, 1984
- Deoxyribonucleotide biosynthesis in yeast (Saccharomyces cerevisiae). A ribonucleotide reductase system of sufficient activity for DNA synthesisEuropean Journal of Biochemistry, 1984
- Growth and the cell cycle of the yeast Saccharomyces cerevisiaeExperimental Cell Research, 1983
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityAnalytical Biochemistry, 1983
- Hypoxanthine: Guanine phosphoribosyltransferase mutants in Saccharomyces cerevisiaeMolecular Genetics and Genomics, 1983
- Two differentially regulated mRNAs with different 5′ ends encode secreted and intracellular forms of yeast invertaseCell, 1982
- Cloning of cDNA for argininosuccinate synthetase mRNA and study of enzyme overproduction in a human cell line.Journal of Biological Chemistry, 1981
- Effect of iron-chelating agents on inhibitors of ribonucleotide reductaseBiochemical Pharmacology, 1981
- Ribonucleotide reductase from calf thymus. Separation of the enzyme into two nonidentical subunits, proteins M1 and M2.Journal of Biological Chemistry, 1980